142 related articles for article (PubMed ID: 18673293)
1. Clinical mass spectrometry proteomic diagnosis by conformal predictors.
Gammerman A; Nouretdinov I; Burford B; Chervonenkis A; Vovk V; Luo Z
Stat Appl Genet Mol Biol; 2008; 7(2):Article13. PubMed ID: 18673293
[TBL] [Abstract][Full Text] [Related]
2. Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis.
Karsan A; Eigl BJ; Flibotte S; Gelmon K; Switzer P; Hassell P; Harrison D; Law J; Hayes M; Stillwell M; Xiao Z; Conrads TP; Veenstra T
Clin Chem; 2005 Aug; 51(8):1525-8. PubMed ID: 15951319
[No Abstract] [Full Text] [Related]
3. SELDI-TOF-MS proteomics of breast cancer.
Clarke CH; Buckley JA; Fung ET
Clin Chem Lab Med; 2005; 43(12):1314-20. PubMed ID: 16309366
[TBL] [Abstract][Full Text] [Related]
4. Constructing support vector machine ensembles for cancer classification based on proteomic profiling.
Mao Y; Zhou XB; Pi DY; Sun YX
Genomics Proteomics Bioinformatics; 2005 Nov; 3(4):238-41. PubMed ID: 16689692
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic proteomics: back to basics?
Master SR
Clin Chem; 2005 Aug; 51(8):1333-4. PubMed ID: 16040839
[No Abstract] [Full Text] [Related]
6. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma.
Dekker TJ; Balluff BD; Jones EA; Schöne CD; Schmitt M; Aubele M; Kroep JR; Smit VT; Tollenaar RA; Mesker WE; Walch A; McDonnell LA
J Proteome Res; 2014 Nov; 13(11):4730-8. PubMed ID: 24762205
[TBL] [Abstract][Full Text] [Related]
7. Fine-needle aspiration in PreservCyt: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF.
Fowler LJ; Lovell MO; Izbicka E
Mod Pathol; 2004 Aug; 17(8):1012-20. PubMed ID: 15195106
[TBL] [Abstract][Full Text] [Related]
8. Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization.
Coombes KR; Fritsche HA; Clarke C; Chen JN; Baggerly KA; Morris JS; Xiao LC; Hung MC; Kuerer HM
Clin Chem; 2003 Oct; 49(10):1615-23. PubMed ID: 14500586
[TBL] [Abstract][Full Text] [Related]
9. Geena 2, improved automated analysis of MALDI/TOF mass spectra.
Romano P; Profumo A; Rocco M; Mangerini R; Ferri F; Facchiano A
BMC Bioinformatics; 2016 Mar; 17 Suppl 4(Suppl 4):61. PubMed ID: 26961516
[TBL] [Abstract][Full Text] [Related]
10. [Proteomics and breast cancer].
Mathelin C; Tomasetto C; Cromer A; Rio MC
Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
[TBL] [Abstract][Full Text] [Related]
11. Proteomic diagnosis competition: design, concepts, participants and first results.
Mertens BJ
J Proteomics; 2009 Jul; 72(5):785-90. PubMed ID: 19375529
[TBL] [Abstract][Full Text] [Related]
12. Case-control breast cancer study of MALDI-TOF proteomic mass spectrometry data on serum samples.
van der Werff MP; Mertens B; de Noo ME; Bladergroen MR; Dalebout HC; Tollenaar RA; Deelder AM
Stat Appl Genet Mol Biol; 2008; 7(2):Article2. PubMed ID: 18241195
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
14. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast.
Somiari RI; Sullivan A; Russell S; Somiari S; Hu H; Jordan R; George A; Katenhusen R; Buchowiecka A; Arciero C; Brzeski H; Hooke J; Shriver C
Proteomics; 2003 Oct; 3(10):1863-73. PubMed ID: 14625848
[TBL] [Abstract][Full Text] [Related]
15. International competition on mass spectrometry proteomic diagnosis.
Mertens B
Stat Appl Genet Mol Biol; 2008; 7(2):Article1. PubMed ID: 19852745
[TBL] [Abstract][Full Text] [Related]
16. [Mass spectrometric proteomic analysis of serum samples--a promising method for early diagnosis of cancer].
Jørgensen PE; Jensen ON; Hørder M
Ugeskr Laeger; 2002 Dec; 165(1):54-5. PubMed ID: 12529953
[No Abstract] [Full Text] [Related]
17. Application of the random forest classification method to peaks detected from mass spectrometric proteomic profiles of cancer patients and controls.
Barrett JH; Cairns DA
Stat Appl Genet Mol Biol; 2008; 7(2):Article4. PubMed ID: 18312218
[TBL] [Abstract][Full Text] [Related]
18. Reliable confidence measures for medical diagnosis with evolutionary algorithms.
Lambrou A; Papadopoulos H; Gammerman A
IEEE Trans Inf Technol Biomed; 2011 Jan; 15(1):93-9. PubMed ID: 21062682
[TBL] [Abstract][Full Text] [Related]
19. Profiling the breast cancer proteome--the new tool of the future?
Grassl J; Morishita M; Lewis PD; Leonard RC; Thomas G
Clin Oncol (R Coll Radiol); 2006 Oct; 18(8):581-6. PubMed ID: 17051946
[No Abstract] [Full Text] [Related]
20. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
Schaub NP; Jones KJ; Nyalwidhe JO; Cazares LH; Karbassi ID; Semmes OJ; Feliberti EC; Perry RR; Drake RR
J Am Coll Surg; 2009 May; 208(5):970-8; discussion 978-80. PubMed ID: 19476873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
